Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa

Published:2022-03-09 Issue:7 Volume:31 Page:1065-1075
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Experimental Dermatology

Author:

Thompson Elizabeth L.¹^ORCID,Pickett‐Leonard Michael²^ORCID,Riddle Megan J.²^ORCID,Chen Weili²^ORCID,Albert Frank W.³^ORCID,Tolar Jakub²⁴^ORCID

Affiliation:

1. Department of Biochemistry, Molecular Biology, and Biophysics University of Minnesota Minneapolis Minnesota USA

2. Department of Pediatrics University of Minnesota Medical School Minneapolis Minnesota USA

3. Department of Genetics, Cell Biology and Development University of Minnesota Minneapolis Minnesota USA

4. Stem Cell Institute University of Minnesota Minnesota USA

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Office of Extramural Research, National Institutes of Health

Children's Cancer Research Fund

National Institute on Aging

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14555

Reference50 articles.

1. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification

2. Procollagen VII Self-Assembly Depends on Site-Specific Interactions and Is Promoted by Cleavage of the NC2 Domain with Procollagen C-Proteinase

3. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

4. Does the position of the premature termination codon in COL7A1 correlate with the clinical severity in recessive dystrophic epidermolysis bullosa?

5. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the current status of CRISPR based clinical trials for rare diseases;International Journal of Biological Macromolecules;2024-10

2. Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa;Scientific Reports;2024-08-16

3. Treatment of Epidermolysis Bullosa and Future Directions: A Review;Dermatology and Therapy;2024-08

4. Practical Tips on Epidermolysis Bullosa for Caregivers: Part 2;Cureus;2024-03-04

5. TGF-β inhibitor treatment of H₂O₂-induced cystitis models provides biochemical mechanism for elucidating interstitial cystitis/painful bladder syndrome patients;PLOS ONE;2023-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3